Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Net Margin

The Net Margin of Halozyme Therapeutics Inc (HALO) is 43.74%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

HALO Net Margin - Historical Value
Date Value
2024-12-31 43.74%
2023-12-31 33.96%
2022-12-31 30.62%
2021-12-31 90.84%
2020-12-31 48.24%
2019-12-31 -36.84%
2018-12-31 -52.86%
2017-12-31 19.90%
2016-12-31 -70.21%
2015-12-31 -23.83%
HALO Net Margin - Peers Comparison